An Automated Cartridge-Based Microfluidic System for Real-Time Quantification of <i>BCR::ABL1</i> Transcripts in Chronic Myeloid Leukemia: An Italian Experience. [PDF]
Danzero AC +12 more
europepmc +1 more source
BCR::ABL1-positive chronic myeloid leukaemia in a scenario of a remote diagnosis of JAK2-V617F-mutated polycythemia vera: a single patient experience with imatinib and ruxolitinib combination therapy. [PDF]
Bartolucci P +7 more
europepmc +1 more source
Under ONIOM Layers: Analysis of BCR-ABL Enzyme Inhibitors Through Bond-Critical Points and Natural Orbitals. [PDF]
Rocha KML, Nascimento ÉCM, Martins JBL.
europepmc +1 more source
Chronic Myeloid Leukemia and the T315I <i>BCR::ABL1</i> Mutation. [PDF]
Pierro F +8 more
europepmc +1 more source
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells. [PDF]
Avinery L +4 more
europepmc +1 more source
Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics. [PDF]
Alqahtani S.
europepmc +1 more source
Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohort. [PDF]
Schweneker K +6 more
europepmc +1 more source
The silent players: Atypical <i>BCR‑ABL </i>isoforms as biomarkers and therapeutic hurdles in CML pathogenesis (Review). [PDF]
Zhou X +5 more
europepmc +1 more source
Rare Atypical Ela3 BCR-ABL transcript in acute Lymphoblastic Leukemia: a case report. [PDF]
Xu L, Han T, Wei S, Wang N.
europepmc +1 more source

